Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000381294 | SCV000339508 | uncertain significance | not provided | 2016-02-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001323432 | SCV001514344 | uncertain significance | X-linked myopathy with postural muscle atrophy | 2023-05-25 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The serine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 286178). This missense change has been observed in individual(s) with clinical features of FHL1-related conditions (PMID: 21520333). This variant is present in population databases (rs774919566, gnomAD 0.001%). This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 85 of the FHL1 protein (p.Asn85Ser). |
Fulgent Genetics, |
RCV002494854 | SCV002782844 | uncertain significance | Myopathy, reducing body, X-linked, childhood-onset; Myopathy, reducing body, X-linked, early-onset, severe; X-linked myopathy with postural muscle atrophy; Uruguay Faciocardiomusculoskeletal syndrome; X-linked scapuloperoneal muscular dystrophy | 2021-09-23 | criteria provided, single submitter | clinical testing |